Upcoming Events
This page is focused on publicly-accessible events related to the CTN and/or hosted by NIDA, Nodes, CTN study teams, or CTN SIGs and committees. We also list some major national/international conferences of particular interest to the Network.
For more national/international conferences and events, visit NIDA’s Meetings & Events page and this list from the journal Addiction.
Events
-
-
CTN T&I SIG: A Scoping Review of Implementation Strategies to Reduce Stigma Toward People Who Use Substances in Healthcare Settings
Webinar/VirtualIn their session, titled, "A Scoping Review of Implementation Strategies to Reduce Stigma Toward People Who Use Substances in Healthcare Settings," Drs. Cioffi and Hartzler will describe the methods, results, and implications of a scoping review completed by the CTN T&I SIG Implementation Strategies Workgroup to identify and describe implementation strategies used to reduce stigmatizing attitudes toward people with SUD in healthcare settings.
-
CTN Primary Care SIG: Whole-Person Primary Care for People Who Use Methamphetamine: Hearts, Lungs, Bugs, and Brains
Webinar/VirtualThe Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices. In their next online meeting, Steven Shoptaw, PhD (UCLA) will present on "Whole-Person Primary Care for People Who Use Methamphetamine: Hearts, Lungs, Bugs, and Brains." Join Zoom Meeting Meeting ID: 943 3434 2090 Passcode: 370819
-
-
Western States Node: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl (CTN-0135)
Webinar/VirtualJoin the CTN Western States Node and the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) for their next joint webinar! In this session, Erin Winstanley, PhD (CTN Appalachian Node), will describe a NIDA Clinical Trials Network study, CTN-0135, examining clinician-reported challenges with initiating buprenorphine for people using fentanyl, including precipitated or prolonged withdrawal, patient reports that buprenorphine was ineffective, and patient preference for methadone. In response to these challenges, most clinicians surveyed reported modifying their standard induction protocols or patient counseling approaches. Clinicians treating larger patient volumes, seeing a high proportion of patients using fentanyl, or initiating treatment in non-inpatient settings were more likely to report difficulties starting patients on buprenorphine. Dr. Winstanley will present the study results and discuss their implications. 1.5 CME/CE credits available! For information about credit types and accreditation, as well as learning objectives for this session, download the webinar flyer.
-
Northeast Node: Innovations in Opioid Use Disorder Treatment (webinar)
Webinar/VirtualThis session will review changes in the opioid overdose crisis and innovations in opioid use disorder treatment, including novel approaches to initiating buprenorphine, use of long-acting injectable buprenorphine, and strategies for methadone initiation in general medical settings.
-
-
CTN Annual Scientific and Steering Committee Meeting
Natcher Building, NIH 45 Center Dr., Bethesda, MD, United StatesThe National Drug Abuse Treatment Clinical Trials Network (CTN) will hold its Annual Scientific and Steering Committee Meeting on Monday-Wednesday, April 13-15, 2026. The meeting will be held at the Natcher Building on the NIH Campus in Bethesda, Maryland. Registration and meeting details coming soon!
-
American Society of Addiction Medicine (ASAM) Annual Conference
Manchester Grand Hyatt 1 Market Pl, San Diego, CA, United StatesThe ASAM Annual Conference is the defining event in addiction medicine, bringing together all professionals to connect, learn, and inspire. For 57 years, ASAM has been convening the addiction treatment community to showcase best practices and the latest science, research, and innovations in the field. This year, attendees will have the opportunity to: Connect and network with over 2,500 colleagues Learn from nationally recognized experts at 60+ sessions and 120+ posters Be Inspired by thought-provoking conversations with peers and powerful presentations highlighting actionable and practical skills
-
-
American Psychiatric Association (APA) Annual Meeting
Join APA in May 2026 as they return to San Francisco for 4.5 days of engaging programming on the future of psychiatry! Registration opens November 12, 2025.
-
Advancing Health Equity Addiction Research in Challenging Times (New Brunswick, NJ)
Rutgers Institute for Health 112 Paterson St., New Brunswick, NJ, United States(NOTE: This is not CTN-related event but may be of interest to CTN members.) Join the Rutgers Resilience Collective for this in-person event on May 22, 2026, 11am-3:30pm ET. This conference is fere to attend. Lunch will be provided for attendees who register by April 15. Students and early-stage investigators may apply for travel awards and data blitz talks. Keynote speaker: Sarah Pederson, PhD: For the Communities Counting on Us: Addiction Research Moves Forward
-
-
College on Problems of Drug Dependence (CPDD) Annual Meeting
Oregon Convention Center 777 NE Martin Luther King Jr. Blvd., Portland, OR, United States2026's CPDD conference will be held June 13-17, 2026 at the Oregon Convention Center in Portland, OR. Check the website for updates!